Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04831645
Previous Study | Return to List | Next Study

The Use of a Dynamic Sustained Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04831645
Recruitment Status : Recruiting
First Posted : April 5, 2021
Last Update Posted : May 25, 2021
Sponsor:
Collaborators:
CurveBeam LLC
Orthopedic Foot and Ankle Center, Ohio
Information provided by (Responsible Party):
MedShape, Inc

Brief Summary:
The purpose of this study is to determine the clinical efficacy of a novel sustained dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis utilizing longitudinal weight-bearing computed tomographic imaging. Of particular focus will be assessment of compressive element recovery and its relation to fusion development over time and weight-bearing status. Additionally, the study will incorporate longitudinal fusion assessment to evaluate differences between three-dimensional weight-bearing computed tomography (WBCT) scans and two-dimensional radiographs (X-rays) at multiple points of the fusion process. Finally, the study will evaluate the differences in WBCT-based fusion assessment between automated and manual methodologies for fusion area calculation.

Condition or disease Intervention/treatment
Ankle Arthritis Arthritis Foot Device: DynaNail Procedure: Tibiotalocalcaneal Arthrodesis

Detailed Description:

This study is a collaborative effort between the Orthopedic Foot and Ankle Center, MedShape, Inc, and CurveBeam. This is a prospective investigation to assess the clinical outcomes of patients with a tibiotalocalcaneal arthrodesis with the Sustained Dynamic Compression Intramedullary Nail (DynaNail), including longitudinal assessment with weight-bearing CT. The investigators plan to enroll 45 patients. No placebo control will be used, as there is no other IM nail available capable of providing sustained compression. Additionally, given that many patients receiving this treatment have had prior failed treatments and face poor alternatives such as amputation, using a prior-generation IM nail as a control treatment would be unethical.

Design:

This is a prospective, single-group study. Patients of the Orthopedic Foot and Ankle Center who are scheduled to undergo TTC arthrodesis will be screened for eligibility and informed consent will be obtained from those who meet the inclusion/exclusion criteria. Subjects will be assessed pre-operatively and then at five post-operative intervals: 1 week, 6 weeks, 3 months, 6 months, and 12 months. A WBCT scan will be obtained at each interval.

Selection of Subjects:

Patients will be identified in the clinic by an attending orthopaedic foot and ankle surgeon or his/her physician assistant based on clinical exam and radiographic findings. Patients will be screened for eligibility by the research coordinator/ key personnel in close coordination with the surgeon and co-investigator.

Pre-operative Questionnaire:

After informed consent, the patients will be asked to complete patient reported outcomes questionnaires that are part of the SOS Registry associated with function and pain, including VAS, VR-12, FFI-R, FAAM, AOS, and AOFAS. The patients will also be asked to provide information related to prior medical history (including potential co-morbidities associated with non-union, i.e. tobacco usage, neuropathy, renal disease, obesity, etc.) and surgical history of the subject lower extremity.

Surgery:

The following surgical procedure is standard of care. The surgical procedure will involve both tibiotalar and talocalcaneal joint preparation through any approach (lateral, posterior, anterior with sinus tarsi). The use of supplemental bone graft is at the discretion of the treating surgeon but must be documented. The MedShape DynaNail will then be inserted according to the manufacturer's technique. The patient will be placed in a short leg splint and kept non-weight bearing initially. The patient will be discharged from the hospital when medically ready. Weight-bearing will start at seven weeks post-surgery.

Follow-Up Visits and Questionnaires:

The patient will return to clinic for visits at the following intervals after surgery: 1 week, 6 weeks, 3 months, 6 months, and 12 months. At each of these time points, a clinical exam will be conducted, and SOS patient questionnaires will be administered, as well as a radiographic and clinical follow-up form. Additionally, radiograph and weight-bearing CT imaging will be obtained of both the ankle and subtalar joints. At 3 months and 12 months post-op, all X-ray and CT images will be de-identified, burned to a DVD, and copies will be sent to both co-sponsors.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 45 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Use of a Dynamic Sustained Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis
Actual Study Start Date : May 24, 2021
Estimated Primary Completion Date : May 24, 2024
Estimated Study Completion Date : May 24, 2024

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Foot Health


Intervention Details:
  • Device: DynaNail
    Utilization of a novel dynamic compression pseudoelastic intramedullary nail
  • Procedure: Tibiotalocalcaneal Arthrodesis
    Tibiotalocalcaneal (TTC) arthrodesis with a novel dynamic compression intramedullary nail.
    Other Names:
    • Subtalar Arthrodesis
    • Tibiotalar Arthrodesis


Primary Outcome Measures :
  1. Fusion [ Time Frame: Pre-Operative to 1 year post-surgery ]
    Joint Fusion, as measured by radiographs and CT scans. Fusion rates will be assessed based on varying CT fusion areas. Fusion rates based on X-Ray vs CT assessment will also be compared. CT fusion rates based on varying fusion areas will be compared with PROM data to assess which fusion area actually corresponds to increased function and reduced pain.


Secondary Outcome Measures :
  1. VAS [ Time Frame: Pre-Operative up to one year post-surgery ]
    Visual Analog Scaled (VAS) - Rates the intensity of pain from 0 - 10 with 10 being the worst pain possible and 0 being no pain.

  2. VR-12 [ Time Frame: Pre-Operative up to one year post-surgery ]
    The Veterans RAND 12 Item Health Survey (VR-12, formerly called the Veterans SF-12) was developed from the Veterans RAND 36 (VR-36, formerly called the Veterans SF-36), which was modified from the original MOS SF-36. The VR-12 measures Physical functioning (PF), social functioning (SF), role limitation due to physical problems (RP), role limitation due to emotional problems (RE), mental health (MH), energy and vitality (VT), bodily pain (BP) and general perception of health (GH). Standard based scoring (sometimes called norm based scoring) is used to calculate the physical component summary (PCS) and mental component summary (MCS) for both measures. The PCS and MCS are standardized using a t-score transformation and normed to a US population at a score of 50 and a standard deviation of 10. Higher scores indicate better health.

  3. FFI-R [ Time Frame: Pre-Operative up to one year post-surgery ]
    Foot Function Index-Revised - Measures the impact of foot pathology on function in terms of pain, disability, and activity restriction. The score is a percentage. The higher the score, the greater the disability.

  4. FAAM [ Time Frame: Pre-Operative up to one year post-surgery ]
    Foot and Ankle Ability Measure - Measures patient capacity for sports and activities of daily living (ADL). The final score is a percentage. The higher final score represents a higher level of physical function.

  5. AOS [ Time Frame: Pre-Operative up to one year post-surgery ]
    Ankle Osteoarthritis Scale - Measures pain levels and difficulty performing various activities of daily living. A line-based scale with range from no pain to the worst pain imaginable.

  6. AOFAS [ Time Frame: Pre-Operative up to one year post-surgery ]
    American Orthopaedic Foot and Ankle Society Scale - Clinician-based outcome that measures foot/ankle pain, function, and alignment. The lower the score, the greater the disability. The maximum score is 100.


Other Outcome Measures:
  1. Automated vs Manual Fusion Assessment [ Time Frame: Up to one year post-surgery ]
    Fusion area calculation over time will be assessed not only by two clinically-trained reviewers, but also using CurveBeam's automated CubeVue assessment software. Averaged clinician results will be compared with CubeVue-calculated data.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients of the Orthopedic Foot and Ankle Center with end-stage tibiotalar (ankle) and talocalcaneal (subtalar) joint arthritis from any etiology will be eligible to enroll in the study. In general, tibiotalar and subtalar arthritis is caused by trauma. Traumatic injuries have no predilection for race, religion, cultural background, etc. Therefore, all demographic groups will have access to this study and should be represented.
Criteria

Inclusion Criteria:

  • Meets indications for TTC arthrodesis and receives the DynaNail implant
  • Able to understand the requirements of the study
  • Willing to comply with the study protocol
  • Sign an Informed consent
  • 18 years of age or older

Exclusion Criteria:

  • Investigator determines that the subject is unlikely to comply with the requirements of the study
  • Non-English speaker
  • Blind
  • Illiterate
  • Prisoner

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04831645


Contacts
Layout table for location contacts
Contact: Kenneth M Dupont, Ph.D. 6782353336 Kenneth.dupont@medshape.com
Contact: Antonio Malloy-McCoy, MPH 614-895-8747 ext 187 mccoyam@orthofootankle.com

Locations
Layout table for location information
United States, Ohio
Orthopedic Foot and Ankle Center Recruiting
Worthington, Ohio, United States, 43085
Contact: Antonio Malloy-McCoy, MPH    614-895-8747 ext 187    mccoyam@orthofootankle.com   
Contact: Gregory C Berlet, MD       berletgc@orthofootankle.com   
Principal Investigator: Gregory C Berlet, MD         
Sub-Investigator: Patrick Bull, DO         
Sub-Investigator: Terrence M Philbin, DO         
Sub-Investigator: Mark A Prissel, DPM         
Sub-Investigator: Christopher F Hyer, DPM         
Sponsors and Collaborators
MedShape, Inc
CurveBeam LLC
Orthopedic Foot and Ankle Center, Ohio
Investigators
Layout table for investigator information
Principal Investigator: Gregory C Berlet, MD Orthopedic Foot and Ankle Center
Layout table for additonal information
Responsible Party: MedShape, Inc
ClinicalTrials.gov Identifier: NCT04831645    
Other Study ID Numbers: MedShape011221
First Posted: April 5, 2021    Key Record Dates
Last Update Posted: May 25, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Keywords provided by MedShape, Inc:
Subtalar Arthrodesis
Intramedullary Nail
Ankle Arthrodesis
Internal Fixation
Sustained Compression
Longitudinal Computed Tomography
Tibiotalar Arthrodesis
Joint Fusion
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthritis
Joint Diseases
Musculoskeletal Diseases